{"title":"Nanofabricated essential oils as a green antifungal agent for the management of aflatoxin B1-producing Aspergillus flavus","authors":"Bhanu Prakash, Tanya Singh Raghuvanshi","doi":"10.1007/s00203-026-04898-3","DOIUrl":null,"url":null,"abstract":"<div><p>Aflatoxin B<sub>1</sub> (AFB<sub>1</sub>) is one of the most common and toxic fungal secondary metabolites in agri-food commodities. AFB<sub>1</sub> has been considered a global threat to food safety and is categorized as a Class 1 human carcinogen. In recent years, due to health concerns associated with currently used synthetic chemicals, a substantial increase in demand for safer alternatives has been observed. In this context, traditionally used plant essential oils (EOs) exhibit remarkable antimicrobial efficacy and could serve as green chemicals to control AFB<sub>1</sub>-producing <i>Aspergillus</i> species. EOs and their nanofabricated formulations often exhibited potent antifungal and anti-aflatoxigenic effects by disrupting fungal cell integrity and simultaneously downregulating aflatoxin biosynthesis genes. Advances in science and technology, especially in molecular biology and nanotechnology, are rejuvenating the industrial application of essential oil-based antimicrobial agents. The use of nanotechnology has extensively helped to overcome major drawbacks such as intense aroma, high volatility, and low dispersibility. This review provides an overview of AFB<sub>1</sub> contamination in agri-food commodities, its biosynthesis, and toxicity. It also discusses the potential use of recent nanotechnological application to enhance the industrial application of EOs-based green antifungal agent for controlling AFB<sub>1</sub>-producing <i>Aspergillus</i> species, along with existing limitations of nanomaterials, encapsulated EOs, regulatory affairs, and future perspectives.</p></div>","PeriodicalId":8279,"journal":{"name":"Archives of Microbiology","volume":"208 8","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Microbiology","FirstCategoryId":"99","ListUrlMain":"https://link.springer.com/article/10.1007/s00203-026-04898-3","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aflatoxin B1 (AFB1) is one of the most common and toxic fungal secondary metabolites in agri-food commodities. AFB1 has been considered a global threat to food safety and is categorized as a Class 1 human carcinogen. In recent years, due to health concerns associated with currently used synthetic chemicals, a substantial increase in demand for safer alternatives has been observed. In this context, traditionally used plant essential oils (EOs) exhibit remarkable antimicrobial efficacy and could serve as green chemicals to control AFB1-producing Aspergillus species. EOs and their nanofabricated formulations often exhibited potent antifungal and anti-aflatoxigenic effects by disrupting fungal cell integrity and simultaneously downregulating aflatoxin biosynthesis genes. Advances in science and technology, especially in molecular biology and nanotechnology, are rejuvenating the industrial application of essential oil-based antimicrobial agents. The use of nanotechnology has extensively helped to overcome major drawbacks such as intense aroma, high volatility, and low dispersibility. This review provides an overview of AFB1 contamination in agri-food commodities, its biosynthesis, and toxicity. It also discusses the potential use of recent nanotechnological application to enhance the industrial application of EOs-based green antifungal agent for controlling AFB1-producing Aspergillus species, along with existing limitations of nanomaterials, encapsulated EOs, regulatory affairs, and future perspectives.
期刊介绍:
Research papers must make a significant and original contribution to
microbiology and be of interest to a broad readership. The results of any
experimental approach that meets these objectives are welcome, particularly
biochemical, molecular genetic, physiological, and/or physical investigations into
microbial cells and their interactions with their environments, including their eukaryotic hosts.
Mini-reviews in areas of special topical interest and papers on medical microbiology, ecology and systematics, including description of novel taxa, are also published.
Theoretical papers and those that report on the analysis or ''mining'' of data are
acceptable in principle if new information, interpretations, or hypotheses
emerge.